Author index, vol. 31 (1978)

489

Atherosclerosis, 31 (1978) 489-494 0 Elsevier/North-Holland Scientific

Publishers,

Ltd.

AUTHOR INDEX, VOL. 31 (1978)

Abdulla, Y.H. and Adams, C.W.M. (The action of human high density lipoprotein on cholesterol crystals, Part 2: Biochemical observations), 473 Abdulla, Y.H., see Adams, C.W.M., 465 Adams, C.W.M. and Abdulla, Y.H. (The action of human high density lipoprotein on cholesterol crystals, Part 1: Lightmicroscopic observations), 465 Adams, C.W.M., see Abdulla, Y.H., 473 Alaupovic, P., see Bojanovski, D., 481 Albert, E.N., Kassira, W.N., Muesing, R. and Vahouny, G.V. (Pyridinolcarbamate and experimental atherosclerosis - Correlation of hypercholesterolemic and antiatherogenic effects), 205 Allen, K.G.D. and Klevay , L.M. (Copper deficiency and cholesterol metabolism in the rat), 259 Apstein, C.S., Zilversmit, D.B., Lees, R.S. and George, P.K. (Effect of intensive plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemia), 105 Ardlie, N.G., see Jakubowski, J.A., 335 Armstrong, M.L., Megan, M.B. and Warner, E.D. (The relation of hypercholesterolemit fatty streaks to intimal permeability changes shown by Evans’ blue), 443 Augustyn, J.M., see Mawhinney, T.P., 155 Avogaro, P., Cazzolato, G., Bittolo Bon, G., Quinci, G.B. and Chinello, M. (HDL-cholesterol, apolipoproteins Ai and B - Age index and body weight), 85 Barter, P.J. and Lally, J.I. (Metabolism of esterified cholesterol in the plasma very low density lipoproteins of the rabbit Studies in vivo and in vitro), 355 Berenson, G.S., see Radhakrishnamurthy, B., 217 Biggs, J.C., see Simons, L.A., 195 Birinyi, F., see Gilbert, D.B., 137 Bittolo Bon, G., see Avogaro, P., 85 Bojanovsky, D., Aloupovic, P., Kelley, J.L. and Stout, C. Isolation and characteriza-

tion of the major lipoprotein density classes of normal and diabetic baboon (Papio onubis) plasma) (Preliminary Note), 481 Bowness, J.M. (Association of structural glycoproteins with lipids or lipoproteins), 403 Bowyer, D.E. and Davies, P.F. (Effect of concentration of perfusing free fatty acid on arterial lipid synthesis in perfused normal and atherosclerotic rabbit aortas), 409 Bradby, G.V.H., see Morris, C.J., 345 Burger, C., see Mehta, J., 169 Campbell, A.E., Loria, R.M. and Madge, G.E. (Coxsackievirus B cardiopathy and angiopathy in the hypercholesterolemic host), 295 Carlo, I.A., see Subbiah,M.T.R., 117 Carlson, L.A. and Wahlberg, G. (Relative increase in apolipoprotein CII content of VLDL and chylomicrons in a case with massive type V hyperlipoproteinaemia by nicotinic acid treatment), 77 Cazzolato, G., see Avogaro, P., 85 Ceredi, C., see Ricci, G., 125 Chinello, M., see Avogaro, P., 85 Christensen, S., see Stender, S., 279 Colombo, M., see Hollander, W., 307 Cucuianu, M., see Cuparencu, B., 435 Cuparencu, B., Horlk, J., Cucuianu, M., Hlncu, N., Negrea, S., Seusan, E. and Vincze, J. (Effects of some benzodiazepine derivatives on fibrinolysis and serum lipids in normolipidaemic rats and in humans), 435 Dalferes, Jr., E.R., see Radhakrishnamurthy, B., 217 Davies, P.F., see Bowyer, D.E., 409 Dembitiska-Kieb, A., see Gryglewski, R.J., 385 Descovich, G., see Ricci, G., 125 Dicke, B.A., see Subbiah, M.T.R., 117 Dinh, D.M., see Subbiah, M.T.R., 117

Dousset, J.C., El Baba, A.M. and Soula, G. (Fatty acid composition of aortic lipids in male and female rabbits), 273 Dukes, D.F., see Gilbert, D.B., 137 El Baba, A.M., see Dousset, J.C., 273 Emole, I., see Ononogbu, I.C., 101 Engblom, J., see Kushwaha, R.S., 65 Farinaro, E., see Ricci, G., 125 Feher, J., see Szondy, E. Fehrsen, S., see Samuel, P., 177 Fletcher, J., see Roach, M.R., 1 Fletcher, T., see Severson, D.L., 21 Foresti, S., see Ricci, G., 125 Fritz, K.E., see Mawhinney, T.P., 155 Fiist, G., see Szondy, E., 251 George, P.K., see Apstein, C.S., 105 GerB, S., see Szondy, E., 251 Gibson, J.C., see Simons, L.A., 195 Gilbert, D.B., Dukes, D.F. and Birinyi, F. (Distinctive protein profiles obtained from extracts of normal and atherosclerotic human aorta), 137 Goldstick, T.K., see Schneiderman, G., 11 Gray, M.V., Hill, J.D. and Mitchell, J.R.A. (Immune mechanisms in patients with proven vascular disease) (Preliminary Note), 377 Groszek, E., and Grundy, S.M. (Electronevidence from particles microscopic smaller than 250 a in ver low density lipoproteins of human plasma), 241 Grundy, D.M., see Groszek, E., 241 Gryglewska, T., see Gryglewski, R.J., 385 Gryglewski, R.J., Dembidska-Kied, A., iumda, A. and Gryglewska, T. (Prostacyclin and thromboxane AZ biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis), 385 Haacke, H., see Parwaresch, M.R., 395 Hancu, N., see Cuparencu, B., 435 Harker, L.A., see Kushwaha, R.S., 65 Hazzard, W.R., see Kushwaha, R.S., 65 Hill, J.D., see Gray, M.V., 377 Hinton, P., see Roach, M.R., 1 Hollander, W., Prusty, S., Nagraj, S., Kirkpatrick, B., Paddock, J. and Colombo, M. (Comparative effects of cetaben (PHB) and dichlormethylene diphosphonate (ClaMDP) on the development of atherosclerosis in the cynomolgus monkey), 307 Horlk, J., see Cuparencu, B., 435 Horvlth, M., see Szondy, E., 251

Isbister,

J.P., see Simons,

L.A., 195

Jakubowski, J.A. and Ardlie, N.G. (Modification of human platelet function by a diet enriched in saturated or polyunsaturated fat), 335 Joffe, B.I., see Shires, R., 59 Kassira, W.N., see Albert, E.N., 205 Kelley, J.L., see Bojanovsky, D., 481 Kirkpatrick, B., see Hollander, W., 307 Klevay, L.M., see Allen, K.G.D., 259 Kothari, H.V. and Kritchevsky, D. (Aortic cholesteryl e&erase - Influence of bile salts), 371 Kottke, B.A., see Subbiah, M.T.R., 117 Kritchevsky, D., Tepper, S.A. and Story, J.A. (Cholesterol vehicle in experimental atherosclerosis, Part 16: Effect of peanut oil on pre-established lesions), 365 Kritchevsky, D., see Kothari, H.V., 371 Hazzard, W.R., Harker, Kushwaha, R.S., L.A. and Engblom, J. (Lipoprotein metabolism in baboons - Effect of feeding cholesterol-rich diet), 65 Lally, J.I., see Barter, P.J., 355 Lang, P.D., see Olsson, A.G., 421, 429 Laurman, W., see Wrodska-Nofer, T., 33 Lees, R.S., see Apstein, C.S., 105 Lenzi, S., see Ricci, G., 125 Lewis, L.A., see Malinow, M.R., 185 Link, E., see Szondy, E., 251 Loria, R.M., see Campbell, A.E., 295 McLaughlin, P., see Malinow, M.R., 185 McNulty, W.P., see Malinow, M.R., 185 Milder, Ch., see Parwaresch, M.R., 395 Madge, G.E., see Campbell, A.E., 295 Malinow, M.R., McLaughlin, P., McNulty, W.P., Naito, H.K. and Lewis, L.A. (Treatment of established atherosclerosis during cholesterol feeding in monkeys), 185 Mancini, M., see Ricci, G., 125 Marcel, Y.L., see Sniderman, A., 327 Masi, I., see Ricci, G., 125 Mawhinney, T.P., Augustyn, J.M. and Fritz, K.E. (Glycosaminoglycan-lipoprotein complexes from aortas of hypercholesterolemic rabbits, Part 1: Isolation and characterization), 155 Megan, M.B., see Armstrong, M.L., 443 Mehta, J., Mehta, P., Burger, C. and Pepine, C.J. (Platelet aggregation studies in coronary artery disease, Part 4: Effect of aspirin), 169 Mehta, P., see Mehta, J., 169

491

Meilman, E., see Samuel, P., 177 Meliota, P., see Ricci, G., 125 Menotti, A., see Ricci, G., 125 Mitchell, J.R.A., see Gray,M.V., 377 Morris, C.J., Bradby, G.V.H. and Walton, K.W. (Fibrous long-spacing collagen in human atherosclerosis), 345 Muesing, R., see Albert, E.N., 205 Nagraj, S., see Hollander, W., 307 Naito, H.K., see Malinow, M.R., 185 Negrea, S., see Cuparencu, B., 435 Nyvad, O., see Stender, S., 279 Olsson, A.G. and Lang, P.D. (Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia), 421 Olsson, A.G., and Lang, P.D. (One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia), 429 Ononogbu, I.C. and Emole, I. (The effect of garri on rat plasma cholesterol), 101 Oriente, P., see Ricci, G., 125 Paddock, J., see Hollander, W., 307 Parwaresch, M.R., Haacke, H. and Milder, Ch. (Efficacy of hypolipidemic treatment in inhibition of experimental atherosclerosis - The effect of nicotinic acid and related compounds), 395 Pepine, C.J., see Mehta, J., 169 Postiglione, L., see Ricci, G., 125 Preau, B., see Radhakrishnamurthy, B., 217 Prusty, S., see Hollander, W., 307 Quinci, G.B., see Avogaro, P., 85 Radhakrishnamurthy, B., Ruiz, H.A., Srinivasan, S.R., Preau, B., Dalferes, Jr., E.R. and Berenson, G.S. (Studies of glycosaminoglycan composition and biologic activity of Vessel@, a hypolipidemic agent), 217 Ricci, G., Masi, I., Menotti, A., Urbinati, G., Mancini, M., Farinaro, E., Oriente, P., Postiglione, L., Lenzi, S., Descovich, G., Ceredi, C., Foresti, S. and Meliota, P. (Blood lipids in Italy - Regional differences), 125 Roach, M.R., Hinton, P. and Fletcher, J. (Artefacts of localization of atherosclerosis in pinned aortas), 1 Robertson, Jr., A.L., see Thorgeirsson, G.S., 231 Rossner, S., (Further studies on serum lipo-

proteins in connective tissue diseases), 93 Ruiz, H.A., see Radhakrishnamurthy, B., 217 Samuel, P., Watermeyer, G., Meilman, E. and Fehrsen, S. (The relationship between serum cholesterol and fecal 7rY-dehydroxylase activity in three ethnic groups in South Africa), 177 Schneiderman, G. and Goldstick, T.K. (Significance of luminal plasma layer resistance in arterial wall oxygen supply), 11 Schwandt, P., see Weisweiler, P., 53 Seftel, H.C., see Shires, R., 59 Seupn, S., see Cuparencu, B., 435 Severson, D.L. and Fletcher, T. (Characterization of cholesterol ester hydrolase activities in rabbit and guinea pig aortas), 21 Shires, R., Joffe, B.I. and Seftel, H.C. (Intravenous fat tolerance on obese Africans with varying grades of carbohydrate tolerance), 59 Simons, L.A., Gibson, J.C., Isbister, J.P. and Biggs, J.C. The effect of plasma exchange on cholesterol metabolism), 195 Sniderman, A., Teng, B., Vezina, C. and Marcel, Y.L. (Cholesterol ester exchange between human plasma high and low density lipoprotein mediated by a plasma protein factor), 327 Soula, G., see Dousset, J.C., 273 Srinivasan, S.R., see Radhakrishnamurthy, B., 217 Stender, S., Christensen, S. and Nyvad, 0. (Uptake of labelled free and esterified cholesterol from plasma by the aortic intima-media tissue measured in vivo in three animal species), 279 Story, J.A., see Kritchevsky, D., 365 Stout, C., see Bojanovski, D., 481 Subbiah, M.T.R., Dicke, B.A., Kottke, B.A., Carlo, LA. and Dinh, D.M. (Regression of naturally occurring atherosclerotic lesions in pigeon aorta by intestinal bypass surgery - Early changes in arterial cholesterol ester metabolism), 117 Szendzikowski, S., see Wrohska-Nofer, T., 33 Szondy, E., Horvlth, M., F&t, G., Link, E., Feher, J. and Gerii, S. (The effect of clofibrate and pyridinol carbamate on the circulating immune complexes and cellular immune response in experimental atherosclerosis), 251 Teng, B., see Sniderman, A., 327

492 Tepper, S.A., see Kritchevsky, D., 365 Thorgeirsson, G.S. and Robertson, Jr., A.L., 231 Urbinati,

G., see Ricci, G., 125

Vahouny, G.V., see Albert, E.N., 205 Vezina, C., see Sniderman, A., 327 Vincze, J., see Cuparencu, B., 435 Wagner, W.D. (Risk factors in pigeons genetically selected for increased atherosclerosis susceptibility), 453 Wahlberg, G., see Carlson, L.A., 71 L. (Lecithin:cholesterol acyl Wallentin, transfer rate and high density lipoproteins in plasma during dietary and clofibrate

treatment of hypertriglyceridemic subjects), 41 Walton, K.W., see Morris, C.J., 345 Warner, E.D., see Armstrong, M.L., 443 Watermeyer, G., see Samuel, P., 177 Weisweiler, P. and Schwandt, P. (Lipid composition of serum lipoproteins in patients with primary type IIb and type IV hyperlipoproteinemia), 53 Wrobska-Nofer, T., Szendzikowski, S. and Laurman, W. (The effect of carbon disulphide and atherogenic diet on the development of atherosclerotic changes in rabbits), 33 Zilversmit, D.B., see Apstein, C.S., 105 Zmuda, A., see Gryglewski, R.J., 385

SUBJECT INDEX, Vol. 31(1978)

Age index, HDL-cholesterol, apolipoproteins A, and B and, 85 Announcements 239,383 Aorta, atherosclerosis, artefacts of localization, 1 -, cholesteryl esterase, influence of bile salts, 371 -, human, protein profiles obtained from extracts of normal and atherosclerotic -, 137 -, intima-media tissue, uptake of cholesterol from plasma by, 279 ester -? in rabbit and guinea pig, cholesterol hydrolase activities, 21 Artery, wall, oxygen supply, significance of luminal plasma layer resistance, 11 effect on platelet aggregation in Aspirin, coronary artery disease, 169 Atherosclerosis, experimental, cholesterol vehicle in, effect of peanut oil on preestablished lesions, 365 - 9-, effect of clofibrate and pyridinolcarbamate on circulating immune complexes, 251 - -, effect of hypolipidaemic treatment, ’ 395 -, -, effect of nicotinic acid, 395 - , -, prostacyclin and thromboxane A* biosynthesis, 385 - -, effects of pyridinolcarbamate, 205 -1 fibrous long-spacing collagen in, 345 -, human aorta, protein profiles from extracts of, 137

-, monkey, effect on development of - by cetaben and dichlormethylene diphosphonate, 307 -, naturally occurring lesions in pigeon aorta, regression by intestinal bypass surgery, 117 -, rabbit, effect of carbon disulphide and atherogenic diet, 33 -, in pinned aortas, artefacts of localization,

.1

-, rabbit aorta, effect of concentration of perfusing free fatty acid on arterial lipid synthesis, 409 -, risk factors in pigeons genetically selected for increased susceptibility to, 453 -, treatment during cholesterol feeding in monkeys, 185 Baboon, lipoprotein metabolism in, effect of cholesterol-rich diet, 65 -, plasma of normal and diabetic, isolation and characterization of major lipoprotein density classes, 481 Benzodiazepine derivatives, effect on fibrinolysis and serum lipids in normolipidaemic rats and in humans, 435 Bezafibrate, dose-response study in hyperIipoproteinaemia, 421 Body weight, HDL-cholesterol, apolipoproteins A, and B and, 85 Carbon disulphide, effect changes in rabbits, 33

on atherosclerotic